Iradimed Co (IRMD) Financials

$83.73

$-2.87 (-3.31%)

As on 04-Sep-2026 13:36EDT

Market cap

$1,113 Mln

Revenue (TTM)

$86 Mln

P/E Ratio

48.6

P/B Ratio

10.9

Div. Yield

0.9 %

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Operating Revenue	86.34	83.81	73.24	65.56	53.30	41.81
Cost of Revenue	20.84	19.49	16.89	15.40	12.02	9.76
Gross Profit	65.50	64.32	56.35	50.16	41.28	32.05
Operating Expenses	37.94	38.18	34.39	30.12	25.65	22.23
Operating Profit (EBIT)	27.56	26.15	21.96	20.04	15.63	9.82
Other Income	--	--	--	--	0.55	0.02
Profit before Tax	29.75	28.36	24.28	21.74	16.18	9.84
Provision for Tax	6.69	5.88	5.04	4.55	3.35	0.51
Profit after Tax (Net Income)	23.05	22.48	19.23	17.19	12.83	9.33
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	12.83	9.33

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Shareholder's Funds	101.75	94.62	86.82	71.42	73.67	72.17
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	4.06	3.98	2.99	4.41	3.29	3.88
Current Liabilities	9.16	10.18	8.51	16.33	8.55	6.82
Total Liabilities	124.14	108.78	98.33	92.16	85.51	82.88

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Non-Current Assets	28.25	27.57	23.08	16.15	8.02	6.64
Current Assets	86.72	81.20	75.24	76.00	77.49	76.24
Total Assets	124.14	108.78	98.33	92.16	85.51	82.88
Total Debt*	--	--	0.15	2.04	2.21	2.48
Net Current Assets	77.56	71.02	66.73	59.67	69.64	69.42

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Cash From Operating Activities	--	24.95	25.62	13.47	10.04	11.26
Cash Flow from Investing Activities	--	-8.42	-8.82	-8.01	-1.37	0.65
Cash from Financing Activities	--	-17.60	-14.34	-13.66	-12.71	0.02
Net Cash Inflow / Outflow	--	--	--	--	-4.04	11.93

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Adjusted EPS ($)	1.79	1.75	1.50	1.35	1.02	0.74
Cash EPS ($)	--	1.84	1.57	1.34	1.07	0.85
Adjusted Book Value ($)	--	7.35	6.79	5.61	5.83	5.71
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	1.94	2.00	1.06	0.80	0.89
Free Cash Flow per Share ($)	--	1.33	1.38	0.43	0.65	0.83

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
ROCE (%)	--	24.76	23.98	23.02	17.04	13.44
ROE (%)	23.48	24.78	24.31	23.70	17.59	13.96
ROA (%)	19.26	21.71	20.20	19.35	15.23	12.12
EBIT Margin (%)	33.88	33.84	33.14	30.56	29.32	23.52
Net Margin (%)	26.70	26.82	26.26	26.22	23.82	22.29
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Revenue Growth (%)	11.21	0.14	0.12	0.23	0.27	0.32
EBIT Growth (%)	12.34	16.83	21.16	28.21	58.88	1,400.94
Net Profit Growth (%)	11.60	16.88	11.87	34.03	37.55	581.19
EPS Growth (%)	11.04	0.16	0.11	0.33	0.38	5.75
Book Value Growth (%)	7.55	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Price / Earnings	48.64	55.72	36.55	35.17	27.85	62.60
Price / Book Value	10.93	13.24	8.10	8.47	4.85	8.09
Dividend Yield (%)	0.89	--	--	--	--	--
EV/EBITDA	36.37	39.08	25.94	27.80	18.50	46.58
Close Price ($)	95.56	97.28	55.00	47.47	28.29	46.21
High Price ($)	107.90	98.53	57.95	51.04	55.92	48.75
Low Price ($)	55.11	47.48	40.18	27.87	26.00	21.65
Market Cap ($ Cr)	1,113.36	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debt to Equity	--	--	0.00	0.03	0.03	0.03
Short term debt to equity ratio	--	--	0.00	0.01	0.00	0.00
Current Ratio	9.46	7.98	8.84	4.65	9.06	11.18
Quick Ratio	8.13	6.84	7.62	3.87	8.43	10.54
Interest Coverage	--	--	--	--	26.86	528.69

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debtors to sales (%)	15.28	16.31	14.41	18.65	24.90	12.28
Asset Turnover	0.72	0.81	0.77	0.74	0.63	0.54
Receivable days	--	52.78	56.80	71.03	63.08	42.42
Inventory Days	--	206.35	251.07	215.66	146.90	153.99
Payable days	--	34.82	40.58	43.35	39.23	26.93
Cash Conversion Cycle	--	224.31	267.29	243.34	170.75	169.48

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement ($ Mln)